Profound Hypogammaglobulinemia 7 Years after Treatment for Indolent Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Profound Hypogammaglobulinemia 7 Years after Treatment for Indolent Lymphoma

Published:2008-01 Issue:4 Volume:26 Page:431-433
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Walker Alison R.,Kleiner Anatole,Rich Lynn,Conners Charlene,Fisher Richard I.,Anolik Jennifer,Friedberg Jonathan W.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/07357900701809068

Reference11 articles.

1. Severe immunodeficiency in patients treated with fludarabine monophosphate

2. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus

3. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

4. Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Severe Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies;Cureus;2024-01-10

2. Risk of Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies;Life;2023-05-28

3. Hypogammaglobulinemia after front-line immunochemotherapy in patients with follicular lymphoma;Journal of Oncology Pharmacy Practice;2023-03-13

4. Rituximab in myasthenia gravis: efficacy, associated infections and risk of induced hypogammaglobulinemia;Neuromuscular Disorders;2022-08

5. Impaired Immune Health in Survivors of Diffuse Large B-Cell Lymphoma;Journal of Clinical Oncology;2020-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3